Wells Fargo analyst Steve Baxter maintained a Sell rating on Molina Healthcare (MOH – Research Report) on January 6 and set a price target of $304.00. The company’s shares closed last Wednesday at $292.08.
According to TipRanks.com, Baxter is a 1-star analyst with an average return of -2.2% and a 61.8% success rate. Baxter covers the Healthcare sector, focusing on stocks such as Agilon Health, UnitedHealth, and Oscar Health.
Molina Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $333.83.
The company has a one-year high of $316.04 and a one-year low of $196.08. Currently, Molina Healthcare has an average volume of 236.4K.
Based on the recent corporate insider activity of 68 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MOH in relation to earlier this year. Most recently, in November 2021, Daniel Cooperman, a Director at MOH sold 5,000 shares for a total of $1,545,650.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Molina Healthcare, Inc. engages in the provision of health care services. It operates through the Health Plans and Other segments. The Health Plans segment consists of health plans in 11 states and the Commonwealth of Puerto Rico and includes direct delivery business. The Other segment includes the historical results of the MMIS and behavioral health subsidiaries. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.
Read More on MOH: